首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.
【24h】

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase.

机译:多巴胺受体激动剂的功能选择性。 I.与腺苷酸环化酶连接的突触后多巴胺D2受体的选择性活化。

获取原文
获取原文并翻译 | 示例
           

摘要

Dihydrexidine (DHX), the first high-affinity D(1) dopamine receptor full agonist, is only 10-fold selective for D(1) versus D(2) receptors, having D(2) affinity similar to the prototypical agonist quinpirole. The D(2) functional properties of DHX and its more D(2) selective analog N-n-propyl-dihydrexidine (PrDHX) were explored in rat brain and pituitary. DHX and PrDHX had binding characteristics to D(2) receptors in rat striatum typical of D(2) agonists, binding to both high- and low-affinity sites and being sensitive to guanine-nucleotides. Consistent with these binding data, both DHX and PrDHX inhibited forskolin-stimulated cAMP synthesis in striatum with a potency and intrinsic activity equivalent to that of quinpirole. Unexpectedly, however, DHX and PrDHX had little functional effect at D(2) receptors expressed on dopaminergic neurons that mediate inhibition of cell firing, dopamine release, or dopamine synthesis. Quantitative receptor competition autoradiography demonstrated that DHX bound to D(2) receptors in striatum (predominantly postsynaptic receptor sites) with equal affinity as D(2) sites in the substantia nigra (autoreceptor sites). The data from these experiments, coupled with what is known about the location of specific dopamine receptor isoforms, lead to the hypothesis that DHX, after binding to D(2L) and D(2S) receptors, causes agonist-typical functional changes only at some of these receptors. This phenomenon (herein termed "functional selectivity") suggests that drugs may be targeted not only at specific receptor isoforms but also at separate functions mediated by a single isoform, yielding novel approaches to drug discovery.
机译:Dihydrexidine(DHX),第一个高亲和力D(1)多巴胺受体完全激动剂,对D(1)与D(2)受体的选择性只有10倍,具有与原型激动剂喹吡罗相似的D(2)亲和力。 DHX的D(2)功能特性及其更多D(2)选择性类似物N-n-丙基-二氢己定(PrDHX)在大鼠脑和垂体中进行了探索。 DHX和PrDHX具有典型的D(2)激动剂的大鼠纹状体中的D(2)受体的结合特征,绑定到高和低亲和力站点和对鸟嘌呤核苷酸敏感。与这些结合数据一致,DHX和PrDHX都抑制了纹状体中福斯高林刺激的cAMP合成,其效力和内在活性与喹吡罗相当。但是,出乎意料的是,DHX和PrDHX对多巴胺能神经元上表达的D(2)受体几乎没有功能作用,这些受体介导抑制细胞释放,多巴胺释放或多巴胺合成。定量受体竞争放射自显影显示,DHX与纹状体中的D(2)受体(主要是突触后受体部位)结合,其亲和力与黑质中的D(2)部位(自身受体部位)相同。这些实验的数据,加上有关特定多巴胺受体同工型的已知信息,导致了这样一个假设:DHX与D(2L)和D(2S)受体结合后,仅在某些地方引起激动剂典型的功能变化。这些受体。这种现象(在此称为“功能选择性”)表明,药物不仅可以靶向特定的受体同工型,而且还可以靶向单一同工型介导的独立功能,从而产生了新的药物发现方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号